septal myectomy

Original Contribution

Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy

10/25/2022

Michael Butzner , DrPH, MPH;

Martin S. Maron , MD;

Phil Sarocco , MSc;

Eric Stanek , PharmD;

Laura A. Robertson , MD;

Chia-Chen Teng ;

Hiangkiat Tan ;

Patients with obstructive hypertrophic cardiomyopathy (oHCM) and severe refractory symptoms may require invasive septal reduction therapies (SRTs), either surgical septal myectomy (SM) or transcatheter alcohol septal ablation (ASA). The main...

Patients with obstructive...

10/25/2022

Journal of Invasive Cardiology

Original Contribution

Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy

01/03/2022

Srikanth Yandrapalli , MD;

Prakash Harikrishnan , MD;

Gabriela Andries , MD;

Srihari S. Naidu , MD;

Julio A. Panza , MD, FACC, FAHA;

Wilbert S. Aronow , MD, AGSF;

In this retrospective observational analysis of the United States Nationwide Readmissions Database years 2012-2014, we identified adults who underwent isolated septal reduction (SR) for OHCM. We studied the differences in short-term outcomes...

In this retrospective...

01/03/2022

Journal of Invasive Cardiology